Annual EBITDA
-$373.62M$1.55B-131.73%
Summary
- Current Value
- As of today, BNTX annual EBITDA is -$373.62M, down -131.73% on
- Historical Performance
- BNTX annual EBITDA is down -101.78% over the past 3 years, and down -123.06% over the past 5 years
- All-Time High Comparison
- BNTX annual EBITDA is currently -101.78% below its historical high of $20.93B set on
- 3-Year Low Comparison
- BNTX annual EBITDA is at its 3-year low
- Sector Comparison
- BNTX annual EBITDA is higher than 3.06% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$373.62M | -131.7% | -101.8% | -123.1% | – | |
| Quarterly EBITDA | $888.56M | +97.5% | -60.7% | +508.9% | +4787.4% | |
| TTM EBITDA | $187.96M | +597.4% | -98.7% | +146.2% | +1091.5% | |
| Price | $106.57 | -6.3% | -26.5% | +3.9% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $2.98B | -27.9% | -86.7% | +2348.5% | – | |
| Annual EPS | -$2.99 | -172.2% | -106.4% | -215.9% | – | |
| Annual EBIT | -$695.96M | -171.1% | -103.3% | -238.8% | – | |
| Annual Net Income | -$719.65M | -171.6% | -105.9% | -258.9% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $16.10B | N/A | -102.3% |
| 5Y | $20.93B | -101.8% | |
| All | $20.93B | -101.8% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$373.62M | at low | |
| 5Y | -$373.62M | at low | |
| All | -$373.62M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$373.62M | -131.7% | |
| $1.18B | -92.7% | |
| $16.10B | -23.1% | |
| $20.93B | +8,159.2% |
| Year | Value | Change |
|---|---|---|
| -$259.75M | -55.1% | |
| -$167.49M | -288.5% | |
| -$43.12M | +27.7% | |
| -$59.61M | - |
FAQ
What is the current annual EBITDA of BNTX?
As of today, BNTX annual EBITDA is -$373.62M
What is 1-year change in BNTX annual EBITDA?
BNTX annual EBITDA is down -131.73% year-over-year
What is 3-year change in BNTX annual EBITDA?
BNTX annual EBITDA is down -101.78% over the past 3 years
How far is BNTX annual EBITDA from its all-time high?
BNTX annual EBITDA is currently -101.78% below its historical high of $20.93B set on December 31, 2021
How does BNTX annual EBITDA rank versus sector peers?
BNTX annual EBITDA is higher than 3.06% of companies in Healthcare sector
When is BNTX next annual earnings release?
The next annual earnings release for BNTX is on
Quarterly EBITDA
$888.56M$1.45B+258.03%
Summary
- Current Value
- As of today, BNTX quarterly EBITDA is $888.56M, up +258.03% on
- Historical Performance
- BNTX quarterly EBITDA is up +97.52% year-over-year, and down -60.71% over the past 3 years
- All-Time High Comparison
- BNTX quarterly EBITDA is currently -83.46% below its historical high of $5.37B set on
- 3-Year Low Comparison
- BNTX quarterly EBITDA is +227.06% above its 3-year low of -$699.32M reached on
- Sector Comparison
- BNTX quarterly EBITDA is higher than 96.56% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $888.56M | +258.0% | +97.5% | -60.7% | +508.9% | |
| Annual EBITDA | -$373.62M | – | -131.7% | -101.8% | -123.1% | |
| TTM EBITDA | $187.96M | +175.0% | +597.4% | -98.7% | +146.2% | |
| Price | $106.57 | +4.2% | -6.3% | -26.5% | +3.9% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.77B | +500.0% | +29.8% | -49.1% | +2151.1% | |
| Quarterly EPS | -$0.14 | +92.3% | -115.7% | -102.0% | +86.4% | |
| Quarterly EBIT | $743.43M | +219.9% | +85.4% | -66.6% | +426.7% | |
| Quarterly Net Income | -$33.54M | +92.3% | -115.4% | -101.9% | +86.3% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $888.56M | at high | |
| 3Y | $3.55B | N/A | -74.9% |
| 5Y | $5.37B | -83.5% | |
| All | $5.37B | -83.5% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$562.29M | +258.0% | |
| 3Y | -$699.32M | +227.1% | |
| 5Y | -$699.32M | +227.1% | |
| All | -$699.32M | +227.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of BNTX?
As of today, BNTX quarterly EBITDA is $888.56M
What is BNTX quarterly EBITDA most recent change?
BNTX quarterly EBITDA was up +258.03% on September 30, 2025
What is 1-year change in BNTX quarterly EBITDA?
BNTX quarterly EBITDA is up +97.52% year-over-year
How far is BNTX quarterly EBITDA from its all-time high?
BNTX quarterly EBITDA is currently -83.46% below its historical high of $5.37B set on September 30, 2021
How does BNTX quarterly EBITDA rank versus sector peers?
BNTX quarterly EBITDA is higher than 96.56% of companies in Healthcare sector
When is BNTX next earnings release?
The next earnings release for BNTX is on
TTM EBITDA
$187.96M$438.71M+174.96%
Summary
- Current Value
- As of today, BNTX TTM EBITDA is $187.96M, up +174.96% on
- Historical Performance
- BNTX TTM EBITDA is up +597.37% year-over-year, and down -98.73% over the past 3 years
- All-Time High Comparison
- BNTX TTM EBITDA is currently -99.10% below its historical high of $20.91B set on
- 3-Year Low Comparison
- BNTX TTM EBITDA is +148.47% above its 3-year low of -$387.78M reached on
- Sector Comparison
- BNTX TTM EBITDA is higher than 86.17% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $187.96M | +175.0% | +597.4% | -98.7% | +146.2% | |
| Annual EBITDA | -$373.62M | – | -131.7% | -101.8% | -123.1% | |
| Quarterly EBITDA | $888.56M | +258.0% | +97.5% | -60.7% | +508.9% | |
| Price | $106.57 | +4.2% | -6.3% | -26.5% | +3.9% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $3.53B | +13.0% | +7.0% | -82.7% | +1796.0% | |
| TTM EPS | -$2.63 | -64.3% | -22.1% | -105.9% | -32.2% | |
| TTM EBIT | -$236.50M | +59.1% | +11.3% | -101.6% | +47.1% | |
| TTM Net Income | -$632.88M | -65.8% | -26.2% | -105.6% | -35.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $187.96M | at high | |
| 3Y | $13.14B | N/A | -98.6% |
| 5Y | $20.91B | -99.1% | |
| All | $20.91B | -99.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$387.78M | +148.5% | |
| 3Y | -$387.78M | +148.5% | |
| 5Y | -$387.78M | +148.5% | |
| All | -$406.63M | +146.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of BNTX?
As of today, BNTX TTM EBITDA is $187.96M
What is BNTX TTM EBITDA most recent change?
BNTX TTM EBITDA was up +174.96% on September 30, 2025
What is 1-year change in BNTX TTM EBITDA?
BNTX TTM EBITDA is up +597.37% year-over-year
How far is BNTX TTM EBITDA from its all-time high?
BNTX TTM EBITDA is currently -99.10% below its historical high of $20.91B set on March 31, 2022
How does BNTX TTM EBITDA rank versus sector peers?
BNTX TTM EBITDA is higher than 86.17% of companies in Healthcare sector
When is BNTX next earnings release?
The next earnings release for BNTX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- BNTX Official Website www.biontech.de
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1776985/000177698525000065/0001776985-25-000065-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1776985/000177698525000013/0001776985-25-000013-index.htm
- BNTX Profile on Yahoo Finance finance.yahoo.com/quote/BNTX
- BNTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bntx